In other studies, transgenic overexpression of TRX by the β-actin promoter protected from the disease or reduced the disease severity in different disease models such as acute hepatitis [18] and ischemic brain injury [19] which are caused mainly by oxidative stress, indicating that TRX has strong cytoprotective properties. The gene discussed is TXN; the disease is Acute hepatitis.